The chemical-pharmaceutical industry is a key sector that stands at the beginning of many value and supply chains and plays a major role as a driver in achieving the ambitious goals of the Green Deal, e. g. in climate protection, and in further advancing digitalisation and high-quality supplies of medicines. Thus, regulatory options for achieving ambitious goals must be designed in such a way that value creation continues to take place in the EU. They must go hand in hand with increasing the ability to innovate and improving the international competitiveness of the industry. Planning security in line with a stable and predictable legal framework is crucial.

Here you find the LANXESS Statement on the REACH Revision.